• News
  • Stock Screener
  • Small Caps
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Review
  • X (Twitter)
  • LinkedIn

Stock Screener

Show:
Sort
Country
Sector
Risk rating
1
2
3
4
5
6
7
Risk factors

    Default risk

    1
    2
    3
    4
    5
    6
    7

    Volatility

    1
    2
    3
    4
    5
    6
    7

    Stress test

    1
    2
    3
    4
    5
    6
    7

    Selling difficulty

    1
    2
    3
    4
    5
    6
    7

    Country risks

    1
    2
    3
    4
    5
    6
    7

    Other risks

    1
    2
    3
    4
    5
    6
    7
Profitability factors

    Valuation

    1
    2
    3
    4
    5
    6
    7

    Analyst view

    1
    2
    3
    4
    5
    6
    7

    Performance

    1
    2
    3
    4
    5
    6
    7

    Profitability

    1
    2
    3
    4
    5
    6
    7

    Growth

    1
    2
    3
    4
    5
    6
    7

    Dividends

    1
    2
    3
    4
    5
    6
    7
    Results: 221

    Sumitomo Pharma Co., Ltd.

    4506.T
    4

    HOYA Corporation

    7741.T
    5

    Takeda Pharmaceutical Company Limited

    4502.T
    6

    Chugai Pharmaceutical Co., Ltd.

    4519.T
    5

    Daiichi Sankyo Company, Limited

    4568.T
    6

    Astellas Pharma Inc.

    4503.T
    5

    Terumo Corporation

    4543.T
    6

    Otsuka Holdings Co., Ltd.

    4578.T
    6

    M3, Inc.

    2413.T
    5

    Shionogi & Co., Ltd.

    4507.T
    6

    Tsuruha Holdings Inc.

    3391.T
    5

    Eisai Co., Ltd.

    4523.T
    6

    Olympus Corporation

    7733.T
    6

    Immuno-Biological Laboratories Co., Ltd.

    4570.T
    2

    Sysmex Corporation

    6869.T
    6

    SanBio Company Limited

    4592.T
    2

    GNI Group Ltd.

    2160.T
    3

    MatsukiyoCocokara & Co.

    3088.T
    3

    COSMOS Pharmaceutical Corporation

    3349.T
    6

    Oncolys BioPharma Inc.

    4588.T
    1
    Show more
X-channel

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2025